Moreover, CD9 may impact tumor sensitivity to radiation therapy by modulating the metastatic and invasive properties of tumor cells (Hori et al., 2004; Herr et al., 2013; Yin et al., 2014; Rappa et al., 2015). This evidence concerns the gene CD9 and neoplasm.